VascVersa secure Invest NI funding

VascVersa have been awarded Invest NI funding. This support from Invest NI will allow us to strengthen our Angicyte portfolio and complete a comprehensive analysis of the clinical grade product. We will work with Queen’s University Belfast for genomic analysis and support.